![Ruth Greferath](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ruth Greferath
Keine laufenden Positionen mehr
Karriereverlauf von Ruth Greferath
Ehemalige bekannte Positionen von Ruth Greferath
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AC IMMUNE SA | Gründer | 13.02.2003 | - |
NormOxys, Inc.
![]() NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Gründer | 03.08.2009 | - |
Corporate Officer/Principal | 31.07.2009 | - |
Ausbildung von Ruth Greferath
Yeshiva University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Schweiz | 2 |
Operativ
Founder | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AC IMMUNE SA | Health Technology |
Private Unternehmen | 1 |
---|---|
NormOxys, Inc.
![]() NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Health Technology |
- Börse
- Insiders
- Ruth Greferath
- Erfahrung